Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder	Active, not recruiting	Phase 2	2024-12-17		NCT04507841

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Guangdong Provincial People's Hospital Affiliated to Southern Medical University	1
Qilu Hospital of Shandong University	249
Renmin Hospital of Wuhan University	73
Sun Yat-Sen University Cancer Center	74
Tongji Hospital	276
West China Second University Hospital	43

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tongji Hospital	Wuhan	China	13